ArticleInflammatory bowel diseases2024
Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab.
Carlos G Gonzalez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it